Annual report pursuant to Section 13 and 15(d)

Stockholders??? Equity and Capitalization - Narrative (Details)

v3.24.1
Stockholders’ Equity and Capitalization - Narrative (Details)
12 Months Ended
Dec. 14, 2023
USD ($)
Nov. 01, 2023
shares
Aug. 18, 2023
USD ($)
shares
Aug. 15, 2023
USD ($)
$ / shares
Feb. 22, 2023
shares
Feb. 16, 2023
USD ($)
$ / shares
shares
Dec. 14, 2022
USD ($)
Nov. 10, 2022
USD ($)
shares
Mar. 02, 2022
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
shares
Feb. 15, 2023
$ / shares
Feb. 05, 2021
shares
Class of Stock [Line Items]                          
Common Stock, Shares Authorized                   100,000,000 20,000,000   100,000,000
Warrants Vested And Outstanding                   3,280,940      
Finance charge from Sciences warrant modification | $                     $ 120,228    
Common stock issued for services (in shares)   5,000           1,665,083 600        
Restricted stock units | $ $ 5,333           $ 5,333            
Amended Credit Agreement                          
Class of Stock [Line Items]                          
Conversion price (in dollars per share) | $ / shares                   $ 9.65   $ 100.00  
MTA Warrants, Credit Consideration                          
Class of Stock [Line Items]                          
Common stock issuance costs | $           $ 1,597,236       $ 1,597,236      
August 2023 PIPE Financing Common Stock Warrants                          
Class of Stock [Line Items]                          
Class Of Warrant or Right, Issued, Acquisition     2,989,981                    
Warrants Vested And Outstanding                   2,325,537      
Payments for Repurchase of Warrants | $     $ 12,000,000                    
Exercise price (in dollars per share) | $ / shares       $ 5.16           $ 5.16      
Finance charge from Sciences warrant modification | $       $ 2,228,638                  
Stock Issued During Period, Shares, New Issues, Acquisition     664,444                    
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | $       (265,053)                  
Gross proceeds from the transaction | $       $ 11,734,947                  
Warrants                          
Class of Stock [Line Items]                          
Warrants exercise (in shares)                   66,566      
Intrinsic value of warrant exercises | $                   $ 332,830      
Warrant exercises (in shares)                   66,566      
Proceeds from warrant exercises | $                   $ 282,906      
Prefunded Warrants                          
Class of Stock [Line Items]                          
Warrants exercise (in shares)                     78,667    
Intrinsic value of warrant exercises | $                     $ 1,178,033    
Warrant exercises (in shares)                     78,667    
Proceeds from warrant exercises | $                   $ 0 $ 1,967    
2022 Common Stock Warrants to Service Provider                          
Class of Stock [Line Items]                          
Warrants Vested And Outstanding                   8,000      
Exercise price (in dollars per share) | $ / shares                   $ 10.00      
2022 Common Stock Warrants to Service Provider | MTA Warrants, Credit Consideration                          
Class of Stock [Line Items]                          
Number of shares issued in transaction (in shares)                   165,517      
2022 Common Stock Warrants to Service Provider | MTA Warrants                          
Class of Stock [Line Items]                          
Exercise price (in dollars per share) | $ / shares           $ 4.25              
Number of shares issued in transaction (in shares)         66,566 66,566              
Common Stock Warrants                          
Class of Stock [Line Items]                          
Proceeds from warrant exercises | $                   $ 11,734,947 $ 0    
Common Stock Warrants | MTA Warrants                          
Class of Stock [Line Items]                          
Exercise price (in dollars per share) | $ / shares           $ 282,906       $ 282,905      
Bird Rock Bio Sub, Inc. (BRB)                          
Class of Stock [Line Items]                          
Asset acquisition, equity interest issued or issuable, number of shares (in shares)     5,436,378                    
Emerald Health Therapeutics Inc                          
Class of Stock [Line Items]                          
Common stock issuance costs | $               $ 25,511          
Exchange ratio               1.95